title: Sublingual immunotherapy: focus on tablets.
authors.affiliation: Allergy and Respiratory Diseases, IRCCS San Martino-IST, University of Genoa, Genoa, Italy. Electronic address: passalacqua@unige.it.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Passalacqua
authors.affiliation: Allergy and Respiratory Diseases, IRCCS San Martino-IST, University of Genoa, Genoa, Italy.
authors.forename: Giorgio Walter
authors.initials: GW
authors.lastname: Canonica
mesh_terms: D000286:Administration, Sublingual; D000328:Adult; D000485:Allergens / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D031164:Ambrosia / Q000009:adverse effects / Q000276:immunology; D000707:Anaphylaxis / Q000209:etiology; D039741:Antigens, Dermatophagoides / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D003233:Conjunctivitis, Allergic / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D000075202:Contraindications; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000191:economics; D004311:Double-Blind Method; D004487:Edema / Q000209:etiology; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D065568:Oral Mucosal Absorption; D010342:Patient Acceptance of Health Care; D006109:Poaceae / Q000009:adverse effects / Q000276:immunology*; D011058:Pollen / Q000009:adverse effects / Q000276:immunology; D011537:Pruritus / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D006255:Rhinitis, Allergic, Seasonal / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D013607:Tablets; D018418:Th2 Cells / Q000276:immunology
chemical_list: D000485:Allergens; D039741:Antigens, Dermatophagoides; D013607:Tablets